Bikiaris et al., 2009 - Google Patents
Novel biodegradable polyester poly (propylene succinate): synthesis and application in the preparation of solid dispersions and nanoparticles of a water-soluble drugBikiaris et al., 2009
View PDF- Document ID
- 13944831895764440945
- Author
- Bikiaris D
- Papageorgiou G
- Papadimitriou S
- Karavas E
- Avgoustakis K
- Publication year
- Publication venue
- Aaps Pharmscitech
External Links
Snippet
Abstract Poly (propylene succinate)(PPSu) polymers of average molecular weights from 2,800 to 13,100 g/mol were synthesized and characterized with regard to crystallinity, thermal properties, and cytocompatibility. Higher molecular weight samples exhibited lower …
- 239000003814 drug 0 title abstract description 55
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/91—Polymers modified by chemical after-treatment
- C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, copolymers of polyalkylene glycol or poloxamer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Papadimitriou et al. | Novel self-assembled core–shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release | |
| Karavelidis et al. | Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior | |
| Bikiaris et al. | Novel biodegradable polyester poly (propylene succinate): synthesis and application in the preparation of solid dispersions and nanoparticles of a water-soluble drug | |
| Peracchia et al. | PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: investigation of their drug encapsulation and release characteristics | |
| Gonzalez et al. | Structural changes of polylactic‐acid (PLA) microspheres under hydrolytic degradation | |
| Karavelidis et al. | Nanoencapsulation of a water soluble drug in biocompatible polyesters. Effect of polyesters melting point and glass transition temperature on drug release behavior | |
| Malhotra et al. | Polymer topology driven enzymatic biodegradation in polycaprolactone block and random copolymer architectures for drug delivery to cancer cells | |
| Kulkarni et al. | Selective enzymatic degradation of poly (ε-caprolactone) containing multiblock copolymers | |
| Zhang et al. | Novel thymopentin release systems prepared from bioresorbable PLA–PEG–PLA hydrogels | |
| Payyappilly et al. | Thermoresponsive biodegradable PEG‐PCL‐PEG based injectable hydrogel for pulsatile insulin delivery | |
| Buwalda et al. | Stereocomplexed 8-armed poly (ethylene glycol)–poly (lactide) star block copolymer hydrogels: gelation mechanism, mechanical properties and degradation behavior | |
| Siafaka et al. | Synthesis of folate-pegylated polyester nanoparticles encapsulating ixabepilone for targeting folate receptor overexpressing breast cancer cells | |
| Hu et al. | Synthesis and characterization of amphiphilic block copolymers with allyl side‐groups | |
| Adami et al. | PLA–PEG copolymers micronization by supercritical assisted atomization | |
| Mohanty et al. | Synthesis and evaluation of MePEG-PCL diblock copolymers: surface properties and controlled release behavior | |
| Nie et al. | Temperature-sensitive star-shaped block copolymers hydrogels for an injection application: Phase transition behavior and biocompatibility | |
| Ding et al. | Ibuprofen-loaded micelles based on star-shaped erythritol-core PLLA-PEG copolymer: effect of molecular weights of PEG | |
| Karavelidis et al. | New thermosensitive nanoparticles prepared by biocompatible pegylated aliphatic polyester block copolymers for local cancer treatment | |
| Tsachouridis et al. | Evaluation of poly (lactic acid)/and poly (lactic-co-glycolic acid)/poly (ethylene adipate) copolymers for the preparation of paclitaxel loaded drug nanoparticles | |
| Kost et al. | pH-tunable nanoparticles composed of copolymers of lactide and allyl-glycidyl ether with various functionalities for the efficient delivery of anti-cancer drugs | |
| Hu et al. | Novel bioresorbable hydrogels prepared from chitosan‐graft‐polylactide copolymers | |
| Sun et al. | Self‐assembled micelles prepared from poly (ɛ‐caprolactone)–poly (ethylene glycol) and poly (ɛ‐caprolactone/glycolide)–poly (ethylene glycol) block copolymers for sustained drug delivery | |
| Chandrasiri et al. | Cross-Linking Poly (Caprolactone)–Polyamidoamine Linear Dendritic Block Copolymers for Theranostic Nanomedicine | |
| Bikiaris et al. | Paliperidone palmitate depot microspheres based on biocompatible poly (alkylene succinate) polyesters as long-acting injectable formulations | |
| Bian et al. | End-chain fluorescent highly branched poly (l-lactide) s: synthesis, architecture-dependence, and fluorescent visible paclitaxel-loaded microspheres |